These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11483646

  • 1. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.
    D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, Kingston AE, Orzi F, De Blasi A, Di Iorio P, Nicoletti F, Bruno V.
    J Neurochem; 2001 Aug; 78(3):435-45. PubMed ID: 11483646
    [Abstract] [Full Text] [Related]

  • 2. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F.
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [Abstract] [Full Text] [Related]

  • 3. Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways.
    Iacovelli L, Bruno V, Salvatore L, Melchiorri D, Gradini R, Caricasole A, Barletta E, De Blasi A, Nicoletti F.
    J Neurochem; 2002 Jul; 82(2):216-23. PubMed ID: 12124422
    [Abstract] [Full Text] [Related]

  • 4. Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors.
    Durand D, Carniglia L, Turati J, Ramírez D, Saba J, Caruso C, Lasaga M.
    Neuropharmacology; 2017 Sep 01; 123():274-286. PubMed ID: 28495373
    [Abstract] [Full Text] [Related]

  • 5. Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.
    Battaglia G, Molinaro G, Riozzi B, Storto M, Busceti CL, Spinsanti P, Bucci D, Di Liberto V, Mudò G, Corti C, Corsi M, Nicoletti F, Belluardo N, Bruno V.
    PLoS One; 2009 Aug 12; 4(8):e6591. PubMed ID: 19672295
    [Abstract] [Full Text] [Related]

  • 6. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G, Riozzi B, Bucci D, Di Menna L, Molinaro G, Pallottino S, Nicoletti F, Bruno V.
    Neurobiol Dis; 2015 Feb 12; 74():126-36. PubMed ID: 25434487
    [Abstract] [Full Text] [Related]

  • 7. Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes.
    Ciccarelli R, D'Alimonte I, Ballerini P, D'Auro M, Nargi E, Buccella S, Di Iorio P, Bruno V, Nicoletti F, Caciagli F.
    Mol Pharmacol; 2007 May 12; 71(5):1369-80. PubMed ID: 17293559
    [Abstract] [Full Text] [Related]

  • 8. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling.
    Bruno V, Sureda FX, Storto M, Casabona G, Caruso A, Knopfel T, Kuhn R, Nicoletti F.
    J Neurosci; 1997 Mar 15; 17(6):1891-7. PubMed ID: 9045718
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta.
    Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, Nicoletti F.
    J Neurosci; 1998 Dec 01; 18(23):9594-600. PubMed ID: 9822720
    [Abstract] [Full Text] [Related]

  • 10. N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.
    Zhu D, Wu X, Strauss KI, Lipsky RH, Qureshi Z, Terhakopian A, Novelli A, Banaudha K, Marini AM.
    J Neurosci Res; 2005 Apr 01; 80(1):104-13. PubMed ID: 15744743
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.
    Fang XX, Jiang XL, Han XH, Peng YP, Qiu YH.
    Cell Mol Neurobiol; 2013 Mar 01; 33(2):241-51. PubMed ID: 23161148
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y, Culmsee C, Klumpp S, Krieglstein J.
    Neuroscience; 2004 Mar 01; 123(4):897-906. PubMed ID: 14751283
    [Abstract] [Full Text] [Related]

  • 13. The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways.
    Melchiorri D, Bruno V, Besong G, Ngomba RT, Cuomo L, De Blasi A, Copani A, Moschella C, Storto M, Nicoletti F, Lepperdinger G, Passarelli F.
    Eur J Neurosci; 2001 May 01; 13(9):1694-702. PubMed ID: 11359521
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase.
    Fuller G, Veitch K, Ho LK, Cruise L, Morris BJ.
    Brain Res Mol Brain Res; 2001 Apr 18; 89(1-2):126-32. PubMed ID: 11311983
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.